申请人:Scott D. Jack
公开号:US20070203183A1
公开(公告)日:2007-08-30
A compound having the general structure of Formula (I):
or a pharmaceutically acceptable salt, solvate, or ester thereof, are useful in treating diseases, disorders, or conditions such as metabolic syndrome (e.g., obesity, waist circumference, lipid profile, and insulin sensitivity), neuroinflammatory disorders, cognitive disorders, psychosis, addictive behavior, gastrointestinal disorders, and cardiovascular conditions.
具有通式(I)的一种化合物,或其药学上可接受的盐、溶剂合物或酯,可用于治疗代谢综合征(例如肥胖、腰围、脂质谱和胰岛素敏感性)、神经炎症性疾病、认知障碍、精神病、成瘾行为、胃肠道疾病和心血管疾病等疾病、疾病或症状。